MIR1249 and neoplasm: At multivariate analysis (considering T stage, N stage, adjuvant chemotherapy and MIR1249 tumor expression), adjuvant treatment (hazard ratio [HR] 0.70; P < 0.001) and MIR1249 expression (HR 0.65; p: 0.004) maintained an independent prognostic value.